Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q4 2022 Earnings Call Transcript

Operator: Greetings, and welcome to Fulcrum Therapeutics Fourth Quarter and Full Year 2022 Earnings Conference Call. As a reminder, this conference is being recorded.

Related Keywords

United States ,Canada ,Santiago ,Regióetropolitana ,Chile ,America ,Matt Biegler ,Alan Ezekowitz ,Acceleron Pharma ,Robertj Gould ,Iain Fraser ,Madhu Kumar ,Ted Tenthoff ,Matthew Biegler ,Edward Tenthoff ,Piper Sandler ,Robert Gould ,Chris Calabrese ,Matthew Harrison ,Judah Frommer ,Esther Rajavelu ,Tazeen Ahmad ,Joseph Schwartz ,Morgan Stanley ,Elevate Bio Company ,Goldman Sachs ,Credit Suisse ,Nasdaq ,Exchange Commission ,Fulcrum Therapeutics Inc ,Lundbeck ,Fulcrum Therapeutics ,Call Transcript March ,Fulcrum Therapeutics Fourth Quarter ,Full Year ,Business Update Conference ,Private Securities Litigation Reform Act ,Interim Chief Executive Officer ,Chief Financial Officer ,Fulcrum Board ,Muscle Fat Infiltration ,Patient Global Impression ,Santiago Arroyo ,Chief Medical Officer ,Vice President ,Clinical Fellow ,Elevate Bio ,Abide Therapeutics ,Dan Gon ,